Mirabegron

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study

Mechanisms for Activation of Beige Adipose Tissue in Humans

Efficacy and Safety of Mirabegron Versus Oxybutynin After Posterior Urethral Valve Ablation

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

Beta-3 Enhanced Autonomic Therapy for POTS

Using Mirabegron to Control Arrhythmia-1

TReating Incontinence for Underlying Mental and Physical Health

Double j Stent Related Symptoms

MIrabegron and Physiological Function in Cold Environments

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure

Activation of Brown Adipose Tissue Metabolism Using Mirabegron

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder